Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

(2018) Toan T. Nguyen et al.   ANNALS OF SURGICAL ONCOLOGY

Patterns of Regression in Breast Cancer after Primary Systemic Treatment

(2018) Tamás Zombori et al.   PATHOLOGY & ONCOLOGY RESEARCH

How Often Is Treatment Effect Identified in Axillary Nodes with a Pathologic Complete Response After Neoadjuvant Chemotherapy?

(2016) Andrea V. Barrio et al.   ANNALS OF SURGICAL ONCOLOGY

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016

(2016) Cornelia Liedtke et al.   Breast Care

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer

(2016) Katsutoshi Enokido et al.   Clinical Breast Cancer

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

(2016) Abigail S. Caudle et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years

(2016) Daniel C. McFarland et al.   Journal of Oncology

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients

(2015) Mila Donker et al.   ANNALS OF SURGERY

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Assessing the Impact of Neoadjuvant Chemotherapy on the Management of the Breast and Axilla in Breast Cancer

(2013) Terri Patricia McVeigh et al.   Clinical Breast Cancer

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

(2012) Nehmat Houssami et al.   EUROPEAN JOURNAL OF CANCER

Totally implantable venous access ports: Retrospective review of long-term complications in 81 patients

(2012) KK Bassi et al.   INDIAN JOURNAL OF CANCER

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

(2012) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer

(2010) Laura S. Dominici et al.   CANCER

First Revision of the German S3 Guideline ‘Diagnosis, Therapy, and Follow-Up of Breast Cancer’

(2008) Achim Wöckel et al.   Breast Care

Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer

(2008) Moshe Zvi Papa et al.   JOURNAL OF SURGICAL ONCOLOGY